Cart
sales@molnova.com
Minamestane
CAS No. 105051-87-4
Minamestane( —— )
Catalog No. M36378 CAS No. 105051-87-4
Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 195 | Get Quote |
|
| 5MG | 304 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 710 | Get Quote |
|
| 50MG | 994 | Get Quote |
|
| 100MG | 1314 | Get Quote |
|
| 500MG | 2628 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMinamestane
-
NoteResearch use only, not for human use.
-
Brief DescriptionMinamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
-
DescriptionMinamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAromatase
-
RecptorAromatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105051-87-4
-
Formula Weight297.39
-
Molecular FormulaC19H23NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)C(=O)CC4)[H])(C=CC1=C(N)C(=O)C=C2)[H])[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Letrozole
Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor that has been introduced for the adjuvant treatment of hormonally-responsive breast Y Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme.
-
Minamestane
Minamestane is a novel irreversible aromatase inhibitor.Minamestane induces time-dependent inhibition of human placental aromatase with a half-life of 4 minutes and a K of 59 nM.Minamestane has antitumor activity.
-
Finrozole
Finrozole (MPV 2213ad) is a novel selective aromatase inhibitor that is partially reversible for breast development.
